AI-generated analysis. Always verify with the original filing.
OS Therapies Incorporated extended the expiration date for its inducement offer to exercise existing warrants from February 10, 2026, to March 2, 2026. The offer involves less than 10 accredited investors exercising warrants for up to 5,382,148 shares at a reduced price of $1.40 per share.
Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. As previously announced, on January 10, 2026, OS Therapies Incorporated (the “Company”) entered into inducement offer letter agreements with les